SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
SciSparc to acquire AutoMax Motors, forming a new entity with SciSparc owning over 50%. SciSparc's core operations to continue.
MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary
Multi-state marijuana operator MariMed has closed the acquisition of Allgreens Dispensary, LLC on Tuesday, April 9, its fifth dispensary in Illinois. The Massachusetts-based company said the green light from the Illinois Department of Financial & Professional Regulation for the license transfer and subsequent closing of the acquisition, allows MariMed to fully consolidate the financial results of the company's Thrive-branded dispensary in Casey, Illinois. Previously, the dispensary has been operated under a managed services agreement. The move comes on the heels of MariMed's last week's acquisition of the operating assets of Our Community Wellness & Compassionate Care Center in Prince George's County in Maryland. Jon Levine, MariMed's CEO and one of the speakers at the Benzinga Cannabis Capital Conference next week, said "maximizing our footprint there [in Maryland] has long been one of our top strategic priorities."
Paramount Directors Exit As Skydance Merger Talks Continue: Report
Investor criticism has surfaced. The deal Paramount is planning may impact the company's nonvoting shareholders.
ContextLogic Urges Stockholders To Vote ‘FOR’ The Value Maximizing Transaction With Qoo10 TODAY
Today is Last Day for ContextLogic Stockholders to Vote at Upcoming Special Meeting Critical that Stockholders Approve Transaction to Protect the Value of their InvestmentNot Voting is the Same as Voting Against the
MorphoSys’ Management Board And Supervisory Board Recommend Shareholders Accept Public Takeover Offer By Novartis For €68.00 Per Share In Cash
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billionShareholders benefit from attractive premium of 94% and 142% on the volume-weighted average price during the last month and
Vertex Pharmaceutical’s Move Beyond Its $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion in cash. Povetacicept, a potent dual antagonist of BAFF and APRIL, shows promise in IgA nephropathy. Transaction expected to close Q2 2024. VRTX expanding into kidney disease treatment.
Revival Gold Acquires Ensign Minerals ‘To Become A Cash-Flowing Mid-Tier US Gold Producer’
Revival Gold ((OTCQX: RVLGF)) has finalized an all-stock deal worth $21.9 million to acquire Ensign Minerals, a privately held exploration company.
Microchip Acquires ADAS And Digital Cockpit Connectivity Pioneer VSI Co. Ltd. To Extend Automotive Networking Market Leadership; Financial Terms Not Disclosed
Microchip Technology Inc. (NASDAQ:MCHP) today announces the completed acquisition of Seoul, Korea-based VSI Co. Ltd., an industry pioneer in providing high-speed, asymmetric, camera, sensor and display connectivity
Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?
Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities.
‘Alpine Immune Is Said To Weigh Options After Takeover Interest’ – BNN Bloomberg
https://www.bnnbloomberg.ca/alpine-immune-is-weighing-options-after-takeover-interest-1.2057499#:~:text=(Bloomberg)%20%2D%2D%20Alpine%20Immune%20Sciences,gained%20as%20much%20as%2017%25